Higher Serum Trough Levels of Tacrolimus Increase 5-Year Allograft Survival in Antibody Positive Renal Transplant Patients.

Zhi-Guo PengJun Tian

Published in: Clinical transplants (2015)

High-dose tacrolimus might play a role in improving allograft survival in HLA or MICA Ab+ post-transplant patients. Increasing tacrolimus concentration might be a plausible treatment for Ab+ post-transplant patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
high dose
peritoneal dialysis